Search results for "critical care and intensive care medicine"

showing 10 items of 682 documents

Deklarierung von Infusionslösungen mit Base Excess (BE) und potentiellem Base Excess (BEpot)

1995

Drug labelingRadiochemistryGeneral MedicineCritical Care and Intensive Care MedicinePlasma SubstitutesLactic acidchemistry.chemical_compoundAnesthesiology and Pain MedicineFluid therapychemistryCarbon dioxideEmergency MedicineBase excessAcid–base reactionAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
researchProduct

Anti-adrenergic effects of ranolazine in isolated rat aorta

2014

Ranolazine, a piperazine derivative, is used as an anti- anginal drug to treat patients with chronic angina in clinical practice [1] and may improve coronary blood flow by reducing compression effects of ischemic contracture, and by improving endothelial function [2],[3]. In the present study we investigate the vascular effects of ranolazine on the endothelium, adrenergic system and Ca2+ in isolated rat aorta.

DrugAortaEndotheliumbusiness.industrymedia_common.quotation_subjectRanolazineAdrenergicChronic anginaBlood flowIschemic ContracturePharmacologyCritical Care and Intensive Care Medicinemedicine.anatomical_structuremedicine.arteryPoster Presentationmedicinebusinessmedicine.drugmedia_commonCritical Care
researchProduct

Ketamine in acute phase of severe traumatic brain injury “an old drug for new uses?”

2021

AbstractMaintaining an adequate level of sedation and analgesia plays a key role in the management of traumatic brain injury (TBI). To date, it is unclear which drug or combination of drugs is most effective in achieving these goals. Ketamine is an agent with attractive pharmacological and pharmacokinetics characteristics. Current evidence shows that ketamine does not increase and may instead decrease intracranial pressure, and its safety profile makes it a reliable tool in the prehospital environment. In this point of view, we discuss different aspects of the use of ketamine in the acute phase of TBI, with its potential benefits and pitfalls.

DrugSecondary insultmedicine.medical_specialtyTime FactorsIntracranial PressureTraumatic brain injurySedationmedia_common.quotation_subjectCritical Care and Intensive Care MedicineNeuroprotectionCooperative sedation03 medical and health sciencesViewpointTraumatic brain injury0302 clinical medicinePharmacokineticsBrain Injuries TraumaticmedicineHumansHypnotics and SedativesKetamineIntensive care medicineIntracranial pressuremedia_commonAnesthetics DissociativeAgitationbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicinelcsh:RC86-88.9medicine.diseaseNeuroprotectionSafety profileSedationKetaminemedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugCritical Care
researchProduct

Corrigendum to “Neuromuscular electrophysiological disorders and muscle atrophy in mechanically-ventilated traumatic brain injury patients: New insig…

2019

Electrophysiologybusiness.industryTraumatic brain injuryAnesthesiaMedicineObservational studymedicine.symptomCritical Care and Intensive Care Medicinebusinessmedicine.diseaseMuscle atrophyJournal of Critical Care
researchProduct

Cardiac arrest and coronavirus disease 2019

2022

The impact of the coronavirus disease 2019 (COVID-19) on the cardiovascular system has been highlighted since the very first weeks after the severe acute respiratory syndrome coronavirus 2 identification. We reviewed the influence of COVID-19 pandemic on cardiac arrest, both considering those occurred out of the hospital (OHCA) and in the hospital (IHCA).An increase in OHCA incidence occurred in different countries, especially in those regions most burdened by the COVID-19, as this seems to be bounded to the pandemic trend. A change of OHCA patients' characteristics, with an increase of the OHCA occurred at home, a decrease in bystander cardiopulmonary resuscitation and automated external d…

Emergency Medical ServicesCOVID-19HumansCritical Care and Intensive Care MedicinePandemicsCardiopulmonary ResuscitationOut-of-Hospital Cardiac ArrestCurrent Opinion in Critical Care
researchProduct

Anti-inflammatory properties of simvastatin on leukocyte-endothelial cell interactions following hemorrhagic shock

2002

Background Hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) have been shown to lower serum cholesterol levels. Recent studies reported that statins have vasculoprotective effects independent of their cholesterol-lowering properties. We studied simvastatin for its ability to modulate leukocyte-endothelial cell interactions under acute inflammation following hemorrhage and reperfusion. Methods The effects of simvastatin on leukocyte-endothelial cell interactions were observed by intravital microscopy in the rat mesenteric microcirculation and by immunohistochemical analyzes. Simvastatin (50 μg/kg or 100 μg/kg) was administrated intraperitoneally 18 h before study. Inf…

EndotheliumP-selectinbusiness.industryLeukocyte RollingEmergency NursingPharmacologyCritical Care and Intensive Care MedicineMicrocirculationEndothelial stem cellThrombinmedicine.anatomical_structureSimvastatinImmunologyEmergency Medicinemedicinelipids (amino acids peptides and proteins)businessIntravital microscopymedicine.drugIntensivmedizin und Notfallmedizin
researchProduct

Palliative Treatment of Dyspnea With Epidural Methadone in Advanced Emphysema

2005

This study investigated whether epidural methadone perfusion at the thoracic level can mitigate dyspnea in patients with advanced emphysema.Open-label clinical trial without a control group.University hospital.The inclusion criteria were a diagnosis of emphysema, basal dyspnea index (Mahler scale)or = 3, FEV(1)or = 35%, and no indication for pneumoreduction or lung transplantation surgery.An epidural catheter was inserted at the thoracic level connected to a perfusion pump for administering methadone (6 mg/24 h). Assessments were made at baseline, 1 week, and 1 month after catheter insertion.Pulmonary function tests were performed, and determinations were made of arterial blood gas levels, …

Epidural SpaceMalePulmonary and Respiratory Medicinemedicine.medical_specialtyPalliative carePalliative treatmentmedicine.medical_treatmentCritical Care and Intensive Care MedicinePulmonary function testingForced Expiratory VolumemedicineHumansLung transplantationIntensive care medicineCatheter insertionbusiness.industryPalliative CareRespiratory diseaseCarbon Dioxidemedicine.diseaseEpidural spacerespiratory tract diseasesSurgeryOxygenCatheterDyspneaTreatment Outcomemedicine.anatomical_structurePulmonary EmphysemaAnesthesiaQuality of LifeArterial bloodFemaleCardiology and Cardiovascular MedicinebusinessMethadoneMethadonemedicine.drugChest
researchProduct

Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes

2021

Funder: Global Initiative for Asthma

ExacerbationRespiratory SystemINHALED CORTICOSTEROIDSCritical Care and Intensive Care MedicineAsthma managementSINGLE-INHALERDOUBLE-BLINDRisk Factorsimmune system diseasesAdrenal Cortex HormonesRELIEVER THERAPYFormoterol FumarateMedicine and Health SciencesImmunology and AllergyAnti-Asthmatic AgentsChild11 Medical and Health SciencesLung functionMILD PERSISTENT ASTHMAExecutive summaryBiologic therapiesCombined Modality TherapyLUNG-FUNCTIONChild PreschoolPractice Guidelines as TopicPerspectiveDisease ProgressionDrug Therapy Combinationmedicine.drugPulmonary and Respiratory MedicineAdultmedicine.medical_specialtyBUDESONIDE/FORMOTEROL MAINTENANCEAdolescentMild asthmaMEDLINEInhaled corticosteroidsCONTROLLED-TRIALSkills trainingGINA Strategy 2021: Executive SummaryBUDESONIDE-FORMOTEROLAdministration InhalationmedicineHumansasthma preventionIntensive care medicineSEVERE EXACERBATIONSAsthmaasthma diagnosisbusiness.industryPatient AcuityInfantasthmamedicine.diseaseAsthmarespiratory tract diseasesSelf Carewf_140Formoterolwf_100businessasthma management
researchProduct

Corrigendum to “Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 Era (PPE-SAFE): An international surve…

2021

The authors regret errors were present in the published article. Counts of some of the adverse events were erroneous. Changes to the text include. Last sentence of the abstract should read. Adverse effects of PPE included heat (1266, 51%), thirst (1174, 47%), pressure areas (1088, 44%), headaches (696, 28%), Inability to use the bathroom (661, 27%) and extreme exhaustion (492, 20%). All but pressure areas were associated with longer shift durations. Last sentence of the results section of the manuscript should read. All but pressure areas were associated with longer duration of shifts wearing PPE (Table 4). Table 1 the total number of community/urban type of hospital should read 740 instead…

Extreme exhaustionCoronavirus disease 2019 (COVID-19)masks COVID19business.industryMEDLINEInternational surveyHealthcare worker030208 emergency & critical care medicineRegretmedicine.diseaseCritical Care and Intensive Care MedicineIntensive care unitlaw.invention03 medical and health sciences0302 clinical medicine030228 respiratory systemlawMedicineMedical emergencyCorrigendumbusinessPersonal protective equipmentJournal of Critical Care
researchProduct

Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey

2020

Purpose To survey healthcare workers (HCW) on availability and use of personal protective equipment (PPE) caring for COVID-19 patients in the intensive care unit (ICU). Materials and method A web-based survey distributed worldwide in April 2020. Results We received 2711 responses from 1797 (67%) physicians, 744 (27%) nurses, and 170 (6%) Allied HCW. For routine care, most (1557, 58%) reportedly used FFP2/N95 masks, waterproof long sleeve gowns (1623; 67%), and face shields/visors (1574; 62%). Powered Air-Purifying Respirators were used routinely and for intubation only by 184 (7%) and 254 (13%) respondents, respectively. Surgical masks were used for routine care by 289 (15%) and 47 (2%) for…

Face shieldMalebusiness.product_categoryHot TemperatureInfectious Disease TransmissionAllied Health PersonnelNursesCritical Care and Intensive Care MedicineOccupational safety and healthlaw.inventionPatient-to-Professional0302 clinical medicinelawSurveys and QuestionnairesPersonal protective equipmentHealth careMedicine and Health SciencesViralRespiratorRespiratory Protective DevicesHealth care workersHealth services researchHeadacheMasksMiddle AgedIntensive care unitEuropeIntensive Care UnitsFemaleSafetyCoronavirus InfectionsEye Protective DevicesThirstAdultmedicine.medical_specialtyCOVID-19; Health care workers; Intensive care; Personal protective equipment; Safety; Adult; Africa; Allied Health Personnel; Asia; Betacoronavirus; COVID-19; Coronavirus Infections; Europe; Eye Protective Devices; Female; Gloves Protective; Headache; Hot Temperature; Humans; Infectious Disease Transmission Patient-to-Professional; Intensive Care Units; Male; Masks; Middle Aged; North America; Nurses; Oceania; Pandemics; Personal Protective Equipment; Personnel Staffing and Scheduling; Physicians; Pneumonia Viral; Respiratory Protective Devices; SARS-CoV-2; South America; Surgical Attire; Surveys and Questionnaires; Thirst; Health Personnel; Occupational HealthInfectious Disease Transmission Patient-to-ProfessionalAsiaHealth PersonnelPneumonia ViralGlovesOceaniaPersonnel Staffing and SchedulingArticle03 medical and health sciencesBetacoronavirusIntensive carePhysiciansmedicineHumansSurgical AttirePersonal protective equipmentPandemicsOccupational Healthbusiness.industrySARS-CoV-2COVID-19030208 emergency & critical care medicinePneumoniaSouth AmericaProtective030228 respiratory systemCOVID-19Personal protective equipmentSafety Health care workersIntensive careIntensive careEmergency medicineAfricaNorth AmericabusinessGloves ProtectiveJournal of Critical Care
researchProduct